FILE:MDT/MDT-8K-20020917140837.txt.gz
EVENTS:	Other events	Financial statements and exhibits
TEXT:
ITEM: Other events
ITEM: Financial statements and exhibits
Table of Contents
Table of Contents
Item 5. Other Events
On September 17, 2002, the Registrant issued a press release announcing that it had repurchased certain of its 1.25% Contingent Convertible Debentures due 2021. The full text of the press release is set forth in Exhibit 99 which is attached hereto and incorporated in this Report as if fully set forth herein.
Item 7. Financial Statements and Exhibits
     Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Table of Contents

 
Exhibit 99
F O R   I M M E D I A T E   R E L E A S E
     MINNEAPOLIS, September 17, 2002  Medtronic, Inc. (NYSE: MDT) announced today that it has repurchased $38,729,000 principal amount of its 1.25% Contingent Convertible Debentures due 2021 from holders that validly exercised their right to require Medtronic to repurchase such debentures on September 16, 2002. The debentures were repurchased in cash at the par value of the principal thereof together with interest accrued thereon. An aggregate of $2,012,500,000 principal amount of the debentures was initially issued and $1,973,771,000 principal amount is currently outstanding. The next date on which holders can require Medtronic to repurchase debentures is September 15, 2004.
     Medtronic, Inc., headquartered in Minneapolis, is the world's leading medical technology company, providing lifelong solutions for people with chronic disease. Its Internet address is www.medtronic.com.


